Pharmacokinetics of the S(+) and R(-) enantiomers of vigabatrin during chronic dosing in a patient with renal failure.
about
Vigabatrin: a novel therapy for seizure disorders.Therapeutic Drug Monitoring of the Newer Anti-Epilepsy MedicationsChiral chromatographic resolution of antiepileptic drugs and their metabolites: a challenge from the optimization to the application.Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval.The use of newer antiepileptic drugs in patients with renal failure.The Pharmacology and Toxicology of Third-Generation Anticonvulsant Drugs.
P2860
Pharmacokinetics of the S(+) and R(-) enantiomers of vigabatrin during chronic dosing in a patient with renal failure.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Pharmacokinetics of the S(+) a ...... a patient with renal failure.
@en
type
label
Pharmacokinetics of the S(+) a ...... a patient with renal failure.
@en
prefLabel
Pharmacokinetics of the S(+) a ...... a patient with renal failure.
@en
P2093
P1476
Pharmacokinetics of the S(+) a ...... a patient with renal failure.
@en
P2093
P304
P356
10.1046/J.1365-2125.1997.00636.X
P407
P577
1997-08-01T00:00:00Z